| Trabectedin |
114899-77-3 |
C39H43N3O11S |
| 2-Mercaptopyridine |
73018-10-7 |
C5H5NS |
| Efmoroctocog alfa |
1270012-79-7 |
|
| 3a-methyl-6a-n-propyl-1,3,4,6-tetramethoxymethyl glycolurea |
220140-29-4 |
C16H30N4O6 |
| Benralizumab |
1044511-01-4 |
|
| Ocrelizumab |
637334-45-3 |
C19H16N2O5 |
| Trastuzumab Deruxtecan |
1826843-81-5 |
|
| Tezepelumab |
1572943-04-4 |
|
| Sarilumab |
1189541-98-7 |
|
| Lecanemab |
1260393-98-3 |
|
| Risankizumab |
1612838-76-2 |
|
| Emicizumab |
1610943-06-0 |
|
| Trastuzumab emtansine |
1018448-65-1 |
C47H64ClN5O13S |
| 2-Methylindole |
95-20-5 |
C9H9N |
| 3-Methylindole |
83-34-1 |
C9H9N |
| Secukinumab |
875356-43-7 |
C237H360In8O42P7 |
| 7-Methylindole |
933-67-5 |
C9H9N |
| Cholecalciferol |
67-97-0 |
C27H44O |
| triarylsulfonium hexafluorophosphate salts in Propylene Carbonate |
109037-77-6 |
C60H47F18P3S5 |
| Eribulin |
253128-41-5 |
C40H59NO11 |
| Compound A |
1665301-36-9 |
C47H63ClN4O14S |
| Compound B |
1704742-19-7 |
C53H75ClN6O15S |
| Compound C |
1281816-04-3 |
C53H75ClN6O15S |
| 1,3,4,6-Tetrakis(butoxymethyl)tetrahydroimidazo(4,5-d)imidazole-2,5(1H,3H)-dione |
15968-37-3 |
C24H46N4O6 |
| Glycoluril |
496-46-8 |
C4H6N4O2 |
| 1-Methylindole |
603-76-9 |
C9H9N |
| Eribulin Mesylate |
441045-17-6 |
C40H59NO11.CH4O3S |
| AP3 Intermidate |
77668-69-0 |
C32H44ClN3O9 |
| 5-Fluoroindole |
399-52-0 |
C8H6FN |
| DM1-SMCC |
1228105-51-8 |
C51H66ClN5O16S |
| Maytansinol |
57103-68-1 |
C28H37ClN2O8 |
| AP3 Intermidate 2 |
138148-68-2 |
C36H50ClN3O10S2 |
| DM4 |
796073-69-3 |
C38H54ClN3O10S |
| DM1 |
139504-50-0 |
C35H48ClN3O10S |
| Aducanumab |
1384260-65-4 |
|
| Dupilumab |
1190264-60-8 |
|
| Tetramethylol acetylenediurea |
5395-50-6 |
C8H14N4O6 |
| 3,9-dihydroxy-6H-dibenzo[b,d]pyran-6-one |
174023-48-4 |
C13H8O4 |
| 2-amino-3-fluorophenol |
53981-23-0 |
C6H6NOF |
| Tirapazamine |
27314-97-2 |
C7H6N4O2 |
| ML385 |
846557-71-9 |
C29H25N3O4S |
| Etanercept |
185243-69-0 |
|
| Alemtuzumab |
216503-57-0 |
|
| Mepolizumab |
196078-29-2 |
C42H66O12 |
| Panitumumab |
339177-26-3 |
|
| Pertuzumab |
380610-27-5 |
|
| Natalizumab |
189261-10-7 |
|
| Tocilizumab |
375823-41-9 |
|
| Dulaglutide |
923950-08-7 |
|
| Atezolizumab |
1380723-44-3 |
|
| Daratumumab |
945721-28-8 |
|
| Secukinumab |
1229022-83-6 |
|
| Ramucirumab |
947687-13-0 |
|
| Omalizumab |
242138-07-4 |
|
| Ustekinumab |
815610-63-0 |
C14H18N5O2Cl3 |
| Eculizumab |
219685-50-4 |
|
| Alirocumab |
1245916-14-6 |
|
| Evolocumab |
1256937-27-5 |
|
| Denosumab |
615258-40-7 |
|
| Vedolizumab |
943609-66-3 |
|
| Ipilimumab |
477202-00-9 |
|
| Bevacizumab |
216974-75-3 |
|
| Infliximab |
170277-31-3 |
|
| Adalimumab |
331731-18-1 |
C6428H9912N1694O1987S46 |
| Cetuximab |
205923-56-4 |
C33H38N4O6.C20H23N7O7.C4H3N2O2F |
| Aflibercept |
845771-78-0 |
|
| Nivolumab |
946414-94-4 |
|
| Triarylsulfonium Hexafluoroantimonate Salts in Propylene Carbonate |
109037-75-4 |
C36H28S3+2.C24H19S2+.3[F6Sb-] |
| Cyclohex-2-enol |
822-67-3 |
C6H10O |
| 2,3,6,7,10,11-hexabromotriphenylene |
82632-80-2 |
C18H6Br6 |
| 2,6-Dibromoanthracene |
186517-01-1 |
C14H8Br2 |
| Pembrolizumab |
1374853-91-4 |
|
| Ethyl 1-benzyl-4,5-dioxopyrrolidine-3-carboxylate |
5336-50-5 |
C14H15NO4 |
| Methyl 5-bromopyrazine-2-carboxylate |
210037-58-4 |
C6H5N2O2Br |
| 4-Bromo-1-(n-propyl)imidazole |
1353856-52-6 |
C6H9N2Br |
| 1H-Imidazole, 2,4,5-tribromo-1-propyl- |
31250-78-9 |
C6H7N2Br3 |
| 4-Bromo-1-(iso-propyl)-1H-imidazole |
623577-60-6 |
C6H9N2Br |
| 4-Bromo-1-ethyl-1H-imidazole |
875340-91-3 |
C5H7N2Br |
| 1H-Imidazole, 2,4,5-tribromo-1-ethyl- |
31250-75-6 |
C5H5N2Br3 |
| Tert-butyl 3-((di-tert-butoxycarbonyl)amino)-5-(1-hydroxyethyl)-1H-pyrazole-1-carboxylate |
1439824-04-0 |
C20H33N3O7 |
| Methyl 4-bromo-2-thiazole-carboxylate |
1025468-06-7 |
C5H4NO2Sbr |
| Urolithin C |
165393-06-6 |
C13H8O5 |
| Urolithin B |
1139-83-9 |
C13H8O3 |
| Thiodiglycolic anhydride |
3261-87-8 |
C4H4O3S |
| ansamitocin P3 |
66584-72-3 |
C32H43N2O9Cl |
| Cyclopropanecarbonitrile |
5500-21-0 |
C4H5N |
| Urolithin A |
1143-70-0 |
C13H8O4 |
| 2-Chloro-4,6-dimethoxy-1,3,5-triazine |
3140-73-6 |
C5H6N3O2Cl |
| (1S,5R)-2-OXABICYCLO[3.3.0]OCT-6-EN-3-ONE |
43119-28-4 |
C7H8O2 |
| 2-Mercaptopyridine |
2637-34-5 |
C5H5NS |
| FingoliMod Base |
162359-55-9 |
C19H33NO2 |
| 4-CloroMethyl-5-Methyl-1,3-dioxol-2-one (DMDO-Cl) |
80841-78-7 |
C5H5O3Cl |
| 4-(hydroxyMethyl)-5-Methyl-l,3-dioxol-2-one |
91526-18-0 |
C5H6O4 |
| (5-broMo-2-Methylphenyl)[5-(4-fluorophenyl)-2-thienyl]- Methanone |
1132832-75-7 |
C18H12OFSbr |
| RS 102895 hydrochloride |
300815-41-2 |
C21H21N2O2F3.HCl |
| GBR-12935;1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine maleate |
76778-22-8 |
C28H34N2O.C4H4O4 |
| BIRB 796 (Doramapimod) |
285983-48-4 |
C31H37N5O3 |
| GW-3965;3-[3-[n-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propvloxy]phenylacetic acid hydrochloride |
405911-17-3 |
C33H31NO3F3Cl.HCl |
| PD 173074;n-[2-[[4-(diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-n'-(1,1-dimethylethyl)urea |
219580-11-7 |
C28H41N7O3 |
| (S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonate |
127191-97-3 |
C38H35N5O6S2 |
